Credit Suisse’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $838K | Buy |
47,877
+6,811
| +17% | +$119K | ﹤0.01% | 2371 |
|
|
2023
Q4 | $894K | Buy |
41,066
+1,125
| +3% | +$24.5K | ﹤0.01% | 2396 |
|
|
2023
Q3 | $613K | Sell |
39,941
-9,196
| -19% | -$141K | ﹤0.01% | 2566 |
|
|
2023
Q2 | $1.17M | Buy |
49,137
+23,299
| +90% | +$554K | ﹤0.01% | 2266 |
|
|
2023
Q1 | $657K | Buy |
25,838
+1,794
| +7% | +$45.6K | ﹤0.01% | 2567 |
|
|
2022
Q4 | $702K | Sell |
24,044
-937
| -4% | -$27.4K | ﹤0.01% | 2561 |
|
|
2022
Q3 | $512K | Buy |
24,981
+7,201
| +41% | +$148K | ﹤0.01% | 2744 |
|
|
2022
Q2 | $206K | Buy |
+17,780
| New | +$206K | ﹤0.01% | 3295 |
|
|
2017
Q4 | – | Sell |
-692
| Closed | -$95K | – | 3627 |
|
|
2017
Q3 | $95K | Buy |
+692
| New | +$95K | ﹤0.01% | 3614 |
|